223 related articles for article (PubMed ID: 31442409)
1. Structural Basis for Allosteric Ligand Recognition in the Human CC Chemokine Receptor 7.
Jaeger K; Bruenle S; Weinert T; Guba W; Muehle J; Miyazaki T; Weber M; Furrer A; Haenggi N; Tetaz T; Huang CY; Mattle D; Vonach JM; Gast A; Kuglstatter A; Rudolph MG; Nogly P; Benz J; Dawson RJP; Standfuss J
Cell; 2019 Aug; 178(5):1222-1230.e10. PubMed ID: 31442409
[TBL] [Abstract][Full Text] [Related]
2. A Comprehensive Computational Screening of Phytochemicals Derived from Saudi Medicinal Plants against Human CC Chemokine Receptor 7 to Identify Potential Anti-Cancer Therapeutics.
Alrumaihi F
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770763
[TBL] [Abstract][Full Text] [Related]
3. Structure of CC chemokine receptor 2 with orthosteric and allosteric antagonists.
Zheng Y; Qin L; Zacarías NV; de Vries H; Han GW; Gustavsson M; Dabros M; Zhao C; Cherney RJ; Carter P; Stamos D; Abagyan R; Cherezov V; Stevens RC; IJzerman AP; Heitman LH; Tebben A; Kufareva I; Handel TM
Nature; 2016 Dec; 540(7633):458-461. PubMed ID: 27926736
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for ligand modulation of the CCR2 conformational landscape.
Taylor BC; Lee CT; Amaro RE
Proc Natl Acad Sci U S A; 2019 Apr; 116(17):8131-8136. PubMed ID: 30975755
[TBL] [Abstract][Full Text] [Related]
5. Structure prediction and molecular dynamics simulations of a G-protein coupled receptor: human CCR2 receptor.
Singh R; Sobhia ME
J Biomol Struct Dyn; 2013; 31(7):694-715. PubMed ID: 22909007
[TBL] [Abstract][Full Text] [Related]
6. Molecular Mechanism of Biased Ligand Conformational Changes in CC Chemokine Receptor 7.
Gaieb Z; Lo DD; Morikis D
J Chem Inf Model; 2016 Sep; 56(9):1808-22. PubMed ID: 27529431
[TBL] [Abstract][Full Text] [Related]
7. Optimization of triazolo[4,5-d]pyrimidines towards human CC chemokine receptor 7 (CCR7) antagonists.
Van Hoof M; Claes S; Proj M; Van Loy T; Schols D; Gobec S; Dehaen W; De Jonghe S
Eur J Med Chem; 2023 May; 251():115240. PubMed ID: 36924670
[TBL] [Abstract][Full Text] [Related]
8. The Inside Story: Crystal Structure of the Chemokine Receptor CCR7 with an Intracellular Allosteric Antagonist.
Saha S; Shukla AK
Biochemistry; 2020 Jan; 59(1):12-14. PubMed ID: 31702904
[No Abstract] [Full Text] [Related]
9. Pyrrolone Derivatives as Intracellular Allosteric Modulators for Chemokine Receptors: Selective and Dual-Targeting Inhibitors of CC Chemokine Receptors 1 and 2.
Ortiz Zacarías NV; van Veldhoven JPD; Portner L; van Spronsen E; Ullo S; Veenhuizen M; van der Velden WJC; Zweemer AJM; Kreekel RM; Oenema K; Lenselink EB; Heitman LH; IJzerman AP
J Med Chem; 2018 Oct; 61(20):9146-9161. PubMed ID: 30256641
[TBL] [Abstract][Full Text] [Related]
10. Revealing the Positive Binding Cooperativity Mechanism between the Orthosteric and the Allosteric Antagonists of CCR2 by Metadynamics and Gaussian Accelerated Molecular Dynamics Simulations.
An X; Bai Q; Bing Z; Liu H; Zhang Q; Liu H; Yao X
ACS Chem Neurosci; 2020 Feb; 11(4):628-637. PubMed ID: 31968162
[TBL] [Abstract][Full Text] [Related]
11. Allosteric and orthosteric sites in CC chemokine receptor (CCR5), a chimeric receptor approach.
Thiele S; Steen A; Jensen PC; Mokrosinski J; Frimurer TM; Rosenkilde MM
J Biol Chem; 2011 Oct; 286(43):37543-54. PubMed ID: 21878623
[TBL] [Abstract][Full Text] [Related]
12. Insights into CC Chemokine Ligand 2/Chemokine Receptor 2 Molecular Recognition: A Step Forward toward Antichemotactic Agents.
David KS; Oliveira ERA; Horta BAC; Valente AP; de Paula VS
Biochemistry; 2017 Jun; 56(25):3197-3210. PubMed ID: 28570817
[TBL] [Abstract][Full Text] [Related]
13. Solution structure of CCL21 and identification of a putative CCR7 binding site.
Love M; Sandberg JL; Ziarek JJ; Gerarden KP; Rode RR; Jensen DR; McCaslin DR; Peterson FC; Veldkamp CT
Biochemistry; 2012 Jan; 51(3):733-5. PubMed ID: 22221265
[TBL] [Abstract][Full Text] [Related]
14. Chemokine (C‑C motif) ligand 21/C‑C chemokine receptor type 7 triggers migration and invasion of human lung cancer cells by epithelial‑mesenchymal transition via the extracellular signal‑regulated kinase signaling pathway.
Zhong G; Chen L; Yin R; Qu Y; Bao Y; Xiao Q; Zhang Z; Shen Y; Li C; Xu Y; Zou Z; Tian H
Mol Med Rep; 2017 Jun; 15(6):4100-4108. PubMed ID: 28487957
[TBL] [Abstract][Full Text] [Related]
15. Discovery and mapping of an intracellular antagonist binding site at the chemokine receptor CCR2.
Zweemer AJ; Bunnik J; Veenhuizen M; Miraglia F; Lenselink EB; Vilums M; de Vries H; Gibert A; Thiele S; Rosenkilde MM; IJzerman AP; Heitman LH
Mol Pharmacol; 2014 Oct; 86(4):358-68. PubMed ID: 25024169
[TBL] [Abstract][Full Text] [Related]
16. Fluorescent Ligands Targeting the Intracellular Allosteric Binding Site of the Chemokine Receptor CCR2.
Toy L; Huber ME; Schmidt MF; Weikert D; Schiedel M
ACS Chem Biol; 2022 Aug; 17(8):2142-2152. PubMed ID: 35838163
[TBL] [Abstract][Full Text] [Related]
17. The HIV-1 Gp120/CXCR4 axis promotes CCR7 ligand-dependent CD4 T cell migration: CCR7 homo- and CCR7/CXCR4 hetero-oligomer formation as a possible mechanism for up-regulation of functional CCR7.
Hayasaka H; Kobayashi D; Yoshimura H; Nakayama EE; Shioda T; Miyasaka M
PLoS One; 2015; 10(2):e0117454. PubMed ID: 25688986
[TBL] [Abstract][Full Text] [Related]
18. Structural Analysis of Chemokine Receptor-Ligand Interactions.
Arimont M; Sun SL; Leurs R; Smit M; de Esch IJP; de Graaf C
J Med Chem; 2017 Jun; 60(12):4735-4779. PubMed ID: 28165741
[TBL] [Abstract][Full Text] [Related]
19. Of Lymph Nodes and CLL Cells: Deciphering the Role of CCR7 in the Pathogenesis of CLL and Understanding Its Potential as Therapeutic Target.
Cuesta-Mateos C; Brown JR; Terrón F; Muñoz-Calleja C
Front Immunol; 2021; 12():662866. PubMed ID: 33841445
[TBL] [Abstract][Full Text] [Related]
20. Conformational heterogeneity in CCR7 undergoes transitions to specific states upon ligand binding.
Gaieb Z; Morikis D
J Mol Graph Model; 2017 Jun; 74():352-358. PubMed ID: 28477575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
